Cover Image

SERUM ADENOSINE DEAMINASE LEVELS IN ACUTE KIDNEY INJURY

SANTHI N NATESAN

Abstract


Acute kidney injury describes a sudden
decline in kidney function over hours and
days. Acute kidney injury is frequently
caused by renal ischemia and represents
an important cause of morbidity and mortality
of hospitalised patients. Ischemic tissue
damage involves several different
mechanisms including renal inflammation,
direct tubular damage, and alteration of
vascular response. Inflammation leads to
leucocytes infiltration and free radicals release
which result in damage to cell membrane
and the release of membrane associated
enzymes like ADA. ADA is a marker
of the T cell activation and hence important
in acute and protracted inflammatory
response. AIMS AND OBJECTIVES-The
aim of the study is to evaluate the serum
adenosine deaminase activity in patients
with acute kidney injury and to establish a
relationship between ADA activity and
acute kidney injury.MATERIALS AND
METHODS-Study group included 50 individuals
aged 20 to 60 years who were
clinically diagnosed as acute kidney injury
with serum creatinine level greater than
1.5 mgdl and the control group included 50
healthy individuals
ADA activity was measured by the
method of Guisti and Glantis using semiautoanalyser.
RESULTS-The mean ADA
activity in the study group (47.53 plus or
minus 8.81) was significantly high when
compared to the control group (22.06 plus
or minus 5.94) and the P value is statistically
significant. ADA activity was significantly
correlated with Serum creatinine
( P value less than 0.01) and blood urea
( P value less than 0.01).CONCLUSIONThe
present study showed an increased
level of ADA in acute kidney injury. Further
elevated ADA indicates that there is
increase in release of free radicals and an
oxidative damage. There is also increased
metabolism of adenosine and loss of
beneficial effects of adenosine in acute
kidney injury. Hence ADA would be a
novel therapeutic intervention in acute kidney
injury and can be used as a routine
marker of acute kidney injury.


Full Text:

PDF

References


Clinical chemistry techniques, principle,

correlation, 6th edition, edited

by Michael L. Bishop, Edward

P.fody, Larry E.schoeff , Chapter 26,

Renal function-kara L. Lynch, Alan

H. B.Wie, Page 537 -540, published

by wolters Kluwer/Lippincott Williams

and Wilkins.

Clinical Biochemistry, 2nd edition,

edited by William J. Marshal,

Stephen K bangerk,Chapter 7,The

kidneys, renal function and renal failure-

Suiphin kon and William J marshal,

page 141-143, published by

Elsevier.

Harrison’s principles of internal

medicine, 18th edition , edited by

Longo,Fau c i , K a r p e r , H a u s e r ,

Jameson, Loscalzo ,. 2nd volume

,Chapter 279, Acute kidney Injury-

Shushrut S Waikar, Joseph

V .Bonventre , page 2293-2299,

Published by Mc Graw Hill.

Kumar & clark’s clinical medicine,

edited by parveen kumar & Michael

Clark,

th edition, Chapter11,Renal disease-

MM Yaqoo, page619-624, published by

Elsevier. 5.Tietz text book of clinical

chemistry and molecular diagnostics, 5th

edition ,edited by Carl A brutis,Edward R.

Ashwood,David E .Burns, Chapter 48,

kidney disease-Michael P Delaney,

Christopher .P.Price, Edmund J.

Lamp, page1555-1559, published by Elsevier

Current medical diagnosis and treatment

, 51st edition, edited by

stephen J .Mcpher, Maxine A .papa dakis,.

page-878,Chapter 22, Kidney disease-

Suzanne watnick, Tonja Dirk x,

published by Mc graw hill

Liano F, Junco E, Pascual J, Madero R,

Verde E. The spectrum of acute renal

failure in the intensive care unit compared

with that seen in other settings.

The Madrid Acute Renal Failure Study

Group. Kidney Int Suppl. 1998, 66: S16-

S24. 8Lippincott s illustrated reviews:

Biochemistry. 4th edition . . Nucleotide

metabolism Pamela C. Champe, Richard

A. Harvey et al.. P. 301.published by New

Delhi: Wolters Kluwer /Lippincott Williams

and Wilkins; 2008.

Jae-Geun Lee, Dong Gu Kang et al.,

Changes in Adenosine deaminase activity

in patients with Type 2 Diabetes Mellitus

and effect of DPP-4 Inhibitor treatment on ADA

activity. Diabetes Metabolism J.2011; April: 35

(2):149-158.

C.Uluoglu, B.Cimen, et al., The effect

of experimental diabetes on the circadian

pattern of adenosine deaminase and

myeloperoxidase activities in rat liver.

Gen. Physiol.Biophys. 2008; 27: 25-31

J.P.J. Ungerer, H.M.Oosthuizen et

al., Serum Adenosine deaminase:

Isoenzymes and diagnostic applications.

Clin.Chem.38/7,1322-1326

(1992).

Andrey V.Zavialov and Ake Engstrom.

Human ADA2 belongs to a

new family of growth factors with

Adenosine deaminase activity. Biochem.

J.( 2005); 391:51-57.

Andrey V.Zavialov, Eduard Gracia

et al., Human Adenosine deaminase

induces differentiation of

monocytes into macrophages and

stimulates proliferation of T-Helper

cells and macrophages. Journal of

leucocytes Biology vol.88 no. 2: 279

-290.

Ayse Binnur Erbagci, Rukiye Deveci,

et al., Effect of intensive insulin

therapy on systemic nitric oxide levels

and adenosine deaminase activity

in secondary sulfonylurea failure.

Biochemia Medica 2009; 19 (2):166

-176.

Iraj Khodadadi, Mohammad Abdi

et al., Analysis of serum adenosine

deaminase (ADA) and ADA1 and

ADA2 isoenzyme activities in HIV

positive and HIV-HBV co-infected

patients. Clinical Biochemistry 44

(2011) 980-983.

George P.H.Leung, Ricky

Y.K.Man, et al. D-Glucose upregulates

adenosine transport in cultured

human aortic smooth muscle.

AJP-Heart June 2005 vol.288 no.

H2756 - H2762. 17.saleema umar

V,Nalini k,ravindra prabu, licy

CD,serum ADA

in acute kidney injury,IJCB,Volume

,supplement 2009,P.136-137.

Vallon, muhlbauer, osswald. Adenosine

and kidney function. American

physiological society, July 2006, volume

, no.3, 901-940

Jessica D. Bauerle, Almut Grenz, Jae-

Hwan Kim, H. Thomas Lee,and Holger K.

Eltzschig. Adenosine Generation and

Signaling during Acute Kidney Injury.J

Am Soc Nephrology 22:14-20, 2011

K.C.Vasudha, A.Nirmal kumar et al.,

Studies on the age dependent changes in

serum Adenosinedeaminase activity . Indian

Journal of Clinical Biochemistry.

; 21 (1): 116-120.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University